Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
Asim Saha, Roddy S. O’Connor, Govindarajan Thangavelu, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 7, pp. 2642-2660
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
Robert Zeiser, Bruce R. Blazar
New England Journal of Medicine (2017) Vol. 377, Iss. 22, pp. 2167-2179
Open Access | Times Cited: 1039
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Kankana Bardhan, Theodora Anagnostou, Vassiliki A. Boussiotis
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 511
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Zijun Y. Xu‐Monette, Jianfeng Zhou, Ken H. Young
Blood (2017) Vol. 131, Iss. 1, pp. 68-83
Open Access | Times Cited: 368
Immune checkpoint inhibitors in challenging populations
Douglas B. Johnson, Ryan J. Sullivan, Alexander M. Menzies
Cancer (2017) Vol. 123, Iss. 11, pp. 1904-1911
Open Access | Times Cited: 302
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Zijun Y. Xu‐Monette, Mingzhi Zhang, Jianyong Li, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 257
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
Ayman Oweida, Mohammad K. Hararah, Andy V. Phan, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 21, pp. 5368-5380
Open Access | Times Cited: 224
Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
Rachel M. Gibbons Johnson, Haidong Dong
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 107
PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells
Xiong Ni, Qingxiao Song, Kaniel Cassady, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 5, pp. 1960-1977
Open Access | Times Cited: 93
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Matthew S. Davids, Haesook T. Kim, Caitlin Costello, et al.
Blood (2020) Vol. 135, Iss. 24, pp. 2182-2191
Open Access | Times Cited: 84
Evolving adeno-associated viruses for gene transfer to the kidney via cross-species cycling of capsid libraries
Alan Rosales, Leo O. Blondel, Joshua A. Hull, et al.
Nature Biomedical Engineering (2025)
Open Access | Times Cited: 1
Biomarkers for posttransplantation outcomes
Sophie Paczesny
Blood (2018) Vol. 131, Iss. 20, pp. 2193-2204
Open Access | Times Cited: 67
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
Thomas Menter, Alexandar Tzankov
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 66
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Le Qin, Ruocong Zhao, Dongmei Chen, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 55
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
Meizhang Li, Rupal P. Soder, Sunil Abhyankar, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 4
Open Access | Times Cited: 54
Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation
Leslie Chávez‐Galán, Andy Ruíz, Karen Martínez‐Espinosa, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 445-445
Open Access | Times Cited: 30
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
Elena Shklovskaya, Helen Rizos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7139-7139
Open Access | Times Cited: 47
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
Ines Malenica, Matteo Donadon, Ana Lleó
Cancers (2020) Vol. 12, Iss. 8, pp. 2190-2190
Open Access | Times Cited: 44
Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation
Marina Chulkina, Ellen J. Beswick, Irina V. Pinchuk
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9165-9165
Open Access | Times Cited: 39
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases
Amke C. Beenen, Tatjana Sauerer, Niels Schaft, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8599-8599
Open Access | Times Cited: 24
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Le Qin, Yuanbin Cui, Tingjie Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy
Leslie S. Kean, Laurence A. Turka, Bruce R. Blazar
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 192-212
Open Access | Times Cited: 47
B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8+ T cells
Xin Liu, Xiaosheng Wu, Siyu Cao, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 40
Biomarkers for Allogeneic HCT Outcomes
Djamilatou Adom, Courtney M. Rowan, Titilayo Adeniyan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 37
Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease
Keli L. Hippen, Ethan G. Aguilar, Stephanie Y. Rhee, et al.
Trends in Immunology (2019) Vol. 41, Iss. 1, pp. 77-91
Open Access | Times Cited: 36
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression
Lalit Batra, Pradeep Shrestha, Hong Zhao, et al.
The Journal of Immunology (2020) Vol. 204, Iss. 10, pp. 2840-2851
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top